Science and Research

Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated COPD Patients (CLAIM): A Double-Blind, Randomised, Crossover Trial

RATIONALE: In the CLAIM study, dual bronchodilation with indacaterol/glycopyrronium (IND/GLY) significantly reduced hyperinflation, which translated into improved cardiac function, measured by left ventricular end-diastolic volume and cardiac output. Pulmonary microvascular blood flow (PMBF) is reduced in COPD; however, the effect of reduced lung hyperinflation on PMBF remains unknown. OBJECTIVES: To determine the effect of lung deflation with IND/GLY on PMBF and regional pulmonary ventilation using magnetic resonance imaging (MRI) in hyperinflated patients with COPD. METHODS: In this double-blind, randomized, two-period crossover study [

  • Vogel-Claussen, J.
  • Schonfeld, C. O.
  • Kaireit, T. F.
  • Voskrebenzev, A.
  • Czerner, C. P.
  • Renne, J.
  • Tillmann, H. C.
  • Berschneider, K.
  • Hiltl, S.
  • Bauersachs, J.
  • Welte, T.
  • Hohlfeld, J. M.

Keywords

  • chronic obstructive pulmonary disease
  • dual bronchodilation
  • lung deflation
  • pulmonary microvascular blood flow
  • regional ventilation
Publication details
DOI: 10.1164/rccm.201805-0995OC
Journal: American journal of respiratory and critical care medicine
Work Type: Original
Location: BREATH
Disease Area: COPD
Partner / Member: MHH, Fraunhofer ITEM
Access-Number: 30641027

DZL Engagements

chevron-down